Burford Capital Limited (BUR) Balance Sheet

The sharp reduction in total assets, from $6.7B to $4.3B, is not due to asset sales but reflects a massive write-down in the litigation portfolio's fair value. This suggests that the quality of asset growth is poor, as the decline is driven by non-cash adjustments rather than organic contraction. The equity base also fell from $2.5B to $819M, indicating that the balance sheet is absorbing significant losses, which may impair future deployment capacity.

The equity/assets ratio fell from 0.48 to 0.34, a substantial decline, suggesting that the capital buffer has been significantly eroded. This may limit the company's ability to absorb further losses or deploy new capital into litigation investments. The negative ROE of -70.9% in 2026Q2 underscores the severity of the earnings shock, which appears to be driven by fair value losses on major cases, including the YPF exposure.

Despite the increase in cash, the liquidity position appears strained given the size of the liability base and the illiquid nature of the litigation assets. The absence of a deposit base means Burford relies on wholesale funding and its own debt, which may become more expensive or constrained if credit markets tighten. The cash balance provides a short-term cushion, but the ongoing negative net interest income suggests that funding costs are a persistent drag.

The consistently negative net interest income reflects the structural mismatch between long-duration litigation assets and the cost of funding them. This negative carry is likely to persist until case resolutions generate realized gains, but the timing is uncertain. Investors should monitor whether the company can reduce funding costs or accelerate realizations to improve the net interest margin.